Alexium International Group Limited · ASX:AJX

Alexium International — Investor Presentation (November 2024)

19 slides from Alexium International's investor presentation, Nov 8, 2024

  1. Slide 1: Investors’ Webinar

    r personal use only ALEXIUM INTERNATIONAL GROUP LIMITED Investors’ Webinar ABN 91 064 820 408 8 November 2024 PRESENTED IN US DOLLARS 1

  2. Slide 2: Contents

    r personal use only  Introduction  FY24 Plan - Recap CONTENTS  FY25 Plan - Overview  Alexium Product Portfolio – Spotlights on mPCM and FR  FY25 – H2 Outlook  Financial Update

  3. Slide 3: Introduction

    Introduction r personal use only FY24 did not yield the targeted financial Culture FR Recapitalisation results, however it was a significant year of Sales mPCM Restructure progress on many fronts.

  4. Slide 4: FY24 Plan - Recap

    FY24 Plan - Recap r personal use only Background: In late 2023 after a two-year slump in revenues from a weak bedding market, Alexium had to pivot and alter its approaches to business and product development. These changes also stepped-up efforts to address the company’s over-concentration of PCM sa

  5. Slide 5: FY25 Plan – Overview

    FY25 Plan – Overview r personal use only In FY25, Alexium has embarked on the next phase of executing our Grow and Diversify Strategy – a plan to aggressively grow revenues in its core and breakthrough markets. We have structured the team to focus on the following five critical focus areas: I. Maint

  6. Slide 6: FY25 Plan – Sales Approach/Key Objectives

    FY25 Plan – Sales Approach/Key Objectives r personal use only Sales Approach: Alexium will continue to develop the experienced sales executives to:  Sell the Company’s products to its current core market (bedding) to further saturate its North American customer base  Diversify the product offering

  7. Slide 7: FY24 – Strategic Pathway

    FY24 – 27 Strategic Pathway r personal use only FY24 FY25 FY26-27 Diversify Diversify Profitable Growth  Team: Build out direct sales and BD  Team: Develop sales and BD teams  Team: Bolster operations team,  Culture: Sales and marketing centric  Culture: Sales and marketing centric mature sales

  8. Slide 8: Strategic Plan - Growth drivers

    FY 25 – 27 Strategic Plan - Growth drivers r personal use only A + B + C = X! A) Maintain – PCM A) Alexium must maintain its foundational PCM sales sales to Bedding to existing customers in North America in its core market of bedding. B) Sales growth through further saturation of that core market, t

  9. Slide 9: Product Portfolio – mPCM – Comfort Technology

    Product Portfolio – mPCM – Comfort Technology r personal use only  Traditional microencapsulated phase  Biobased microencapsulated phase change change material (petroleum based) material (plant derived)  Effective on textiles and foam  USDA Bio-Preferred Certified (mPCM) with  Premium PCM cooli

  10. Slide 10: Product Enhancements Driving Near-Term Growth

    Product Enhancements Diving Near-Term Growth: r personal use only AlexiCool® and BioCool® have been the primary sources of the Company’s revenue in recent periods. In late FY24, the Company revised its market strategy for mPCM. The strategic change led to the company producing its own petroleum-base

  11. Slide 11: Product Portfolio - Flame Retardant Technologies

    Product Portfolio - Flame Retardant Technologies r personal use only  Customised solutions  Flame retardant emulsion  Flame retardant emulsion for use for use on 100% polyester on 100% synthetic and natural  Designed for use in a variety fabric fibers and fabrics of markets: FR suits (PPE),  No

  12. Slide 12: Product Enhancements Driving Near-Term Growth

    Product Enhancements Diving Near-Term Growth: r personal use only AlexiShield is the Company’s latest development in FR coatings. In early FY24, the Company developed an advanced FR formulation that is free of any banned substances, and free of substances with proposed bans. The initiative was fast-

  13. Slide 13: Product Portfolio – Thermal Regulation Materials

    Product Portfolio – Thermal Regulation Materials r personal use only  Textile composite based on a  Textile composite for adaptive patent pending, first-in-class thermal regulation technology  Easily integrated into several  Made from comfortable, multi- end-product applications stretch textiles

  14. Slide 14: Alexium Pillow

    Alexium Pillow: Alexium has developed a luxury pillow that incorporates two of the Company’s technologies. The concept originated as a simple marketing tool with the pillow prototype to be utilised as a r personal use only way to demonstrate the company’s DelCool and AlexiCool® technologies. We star

  15. Slide 15: Q2 & H2 Outlook

    Despite the sluggish start in Q1, the Company r personal use only expects to catch up on the trailing results over the balance of the Fiscal Year. There are several new opportunities in the Pipeline that are expected to close in Q2 and early Q3. These are expected to start in H2 and ramp to full rat

  16. Slide 16: Financial Update

    r personal use only Financial Update 16

  17. Slide 17: Renegotiation & Extension of Line of Credit

    r personal use only The Company has an outstanding asset-based line of credit (LOC) with Alterna Capital Solutions (ACS). The LOC has a stated maximum funding of $3.0 million Renegotiation which can be increased to $5.0 million with the approval of the lender. The borrowing base of the LOC consists

  18. Slide 18: Cash Flow Commentary

    Alexium continues to apply a disciplined approach of prioritising short-term r personal use only revenue opportunities while advancing secondary new business focus areas to ensure medium-to-long-term growth objectives are met. The Company has been applying the same level of discipline to managing ex

  19. Slide 19: Cash Flow Commentary

    Operating activity outflows (refer to Appendix 4C Item 1) primarily consist of raw material purchases, manufacturing costs, staffing costs, and r personal use only corporate/administrative costs. The Company experienced a quarter-over- quarter decrease in interest expenses of US$0.1 million due to t

Alexium International Group — Investor Presentation (November 2024) on 6ix